CA2020200A1 - Utilisation du sucralfate - Google Patents

Utilisation du sucralfate

Info

Publication number
CA2020200A1
CA2020200A1 CA 2020200 CA2020200A CA2020200A1 CA 2020200 A1 CA2020200 A1 CA 2020200A1 CA 2020200 CA2020200 CA 2020200 CA 2020200 A CA2020200 A CA 2020200A CA 2020200 A1 CA2020200 A1 CA 2020200A1
Authority
CA
Canada
Prior art keywords
sucralfate
skin
treatment
preparation
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2020200
Other languages
English (en)
Inventor
Daniel Bar-Shalom
Niels Bukh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Buhk Meditec AS
Original Assignee
Buhk Meditec AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Buhk Meditec AS filed Critical Buhk Meditec AS
Priority to CA 2020200 priority Critical patent/CA2020200A1/fr
Publication of CA2020200A1 publication Critical patent/CA2020200A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2020200 1990-06-29 1990-06-29 Utilisation du sucralfate Abandoned CA2020200A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2020200 CA2020200A1 (fr) 1990-06-29 1990-06-29 Utilisation du sucralfate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2020200 CA2020200A1 (fr) 1990-06-29 1990-06-29 Utilisation du sucralfate

Publications (1)

Publication Number Publication Date
CA2020200A1 true CA2020200A1 (fr) 1991-12-30

Family

ID=4145382

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2020200 Abandoned CA2020200A1 (fr) 1990-06-29 1990-06-29 Utilisation du sucralfate

Country Status (1)

Country Link
CA (1) CA2020200A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014127475A1 (fr) * 2013-02-19 2014-08-28 Hochman David Jonathan Composition thérapeutique pour le traitement de troubles périanaux
EP2810641A1 (fr) * 2013-05-31 2014-12-10 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Préparations pharmaceutiques et des dispositifs médicaux topiques contenant des combinaisons de sucralfate, l'acide hyaluronique, l'arginine et un emolient naturel
WO2015177379A3 (fr) * 2014-05-23 2016-02-04 Reponex Pharmaceuticals Aps Compositions destinées à favoriser la cicatrisation des plaies
US10105415B2 (en) 2014-07-24 2018-10-23 Reponex Pharmaceuticals A/S Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
WO2020076501A1 (fr) * 2018-10-10 2020-04-16 Hollister Incorporated Poudre pour stomie comprenant des ingrédients de santé de la peau

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014127475A1 (fr) * 2013-02-19 2014-08-28 Hochman David Jonathan Composition thérapeutique pour le traitement de troubles périanaux
EP2810641A1 (fr) * 2013-05-31 2014-12-10 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Préparations pharmaceutiques et des dispositifs médicaux topiques contenant des combinaisons de sucralfate, l'acide hyaluronique, l'arginine et un emolient naturel
WO2015177379A3 (fr) * 2014-05-23 2016-02-04 Reponex Pharmaceuticals Aps Compositions destinées à favoriser la cicatrisation des plaies
JP2017524655A (ja) * 2014-05-23 2017-08-31 レポネックス・ファーマシューティカルズ・エーピーエス 創傷の治癒を促進するための組成物
US11813309B2 (en) 2014-05-23 2023-11-14 Reponex Pharmaceuticals Aps Method of alleviating chronic wounds
US10105415B2 (en) 2014-07-24 2018-10-23 Reponex Pharmaceuticals A/S Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
WO2020076501A1 (fr) * 2018-10-10 2020-04-16 Hollister Incorporated Poudre pour stomie comprenant des ingrédients de santé de la peau

Similar Documents

Publication Publication Date Title
EP0640346B1 (fr) Utilisations de sucres sulfates contre inflammation
US5908836A (en) Protecting skin from radiation damage using sulphated sugars
US5583119A (en) Hyaluronic acid-urea pharmaceutical compositions and uses
JP5118633B2 (ja) 医療用デバイスおよび医薬製剤において有用な粘膜付着性キシログルカン含有製剤
US5234914A (en) Methods of treating hemorrhoids and anorecial disease
EP0822816B1 (fr) Preparation dermatologique destine au traitement des keratoses actiniques
US4708873A (en) Method of chemically debriding uncerated necrotic tissue
US5550112A (en) Hyaluronic acid-urea pharmaceutical compositions and uses
EP0988040B1 (fr) Utilisation de glucosamine et de derives de glucosamine pour le soulagement rapide de prurit ou de douleurs localisees
US6051244A (en) Fructose diphosphate topical compositions
WO1994015623A9 (fr) Compositions pharmaceutiques a base d'acide hyaluronique et d'uree, et leurs utilisations
US4107330A (en) Topical application of thioglycolic acid in the treatment of acne
BRPI0715361A2 (pt) uso de polietileno glicol em inflamaÇço relacionada com doenÇas ou distérbios tàpicos e cicatrizaÇço de ferimento
CA2020200A1 (fr) Utilisation du sucralfate
US5565189A (en) Wound cleanser method of use
CA2020199C (fr) Utilisation de sucres sulfates
JPS5877824A (ja) インターフェロンを含む組成物
JP2723473B2 (ja) 硫酸化糖類の用途
DK174560B1 (da) Anvendelse af sulfaterede sukkerarter til fremstilling af et præparat til behandling af skæl
AU664419B2 (en) Use of sulphated sugars
RU2190388C1 (ru) Средство на основе масла чайного дерева (варианты)
DK169606B1 (da) Anvendelse af sulfaterede saccharider til fremstilling af præparater, og præparater indeholdende sulfaterede saccharider
WO2006121209A1 (fr) Agent thérapeutique contre l'eczéma et la dermatite
IT202000003934A1 (it) Formulazione a base naturale per l’uso nel trattamento di disturbi proctologici
MXPA97007850A (en) Actin dermatological preparation

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19970630